Samrat Pharmachem Limited (BOM:530125)
India
· Delayed Price · Currency is INR 211.50
+1.55 (0.74%)
At close: Apr 28, 2026
Samrat Pharmachem Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Net Income | - | 71.12 | 21.63 | 166.31 | 171.85 | 53.33 | Upgrade
|
| Depreciation & Amortization | - | 6.53 | 6.46 | 6.42 | 5.94 | 4.93 | Upgrade
|
| Other Amortization | - | 0.02 | 0.01 | 0.01 | 0.01 | 0 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 0.95 | -0.18 | - | 0.23 | 0.18 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -4.05 | -9.87 | -0.23 | -0.08 | - | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | - | - | 0.23 | -0.01 | Upgrade
|
| Other Operating Activities | - | 16.24 | -22.23 | -25.7 | 54.35 | 9.48 | Upgrade
|
| Change in Accounts Receivable | - | 127.45 | -176.06 | -80.99 | -106.09 | -51.93 | Upgrade
|
| Change in Inventory | - | -173.28 | 118.51 | -201.12 | -10.16 | 73.68 | Upgrade
|
| Change in Accounts Payable | - | -91.07 | 157.88 | 84.89 | 57.33 | -54.29 | Upgrade
|
| Change in Other Net Operating Assets | - | -54.81 | -2.03 | -43.96 | 1.13 | 12.61 | Upgrade
|
| Operating Cash Flow | - | -100.91 | 94.12 | -94.37 | 174.74 | 47.98 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | - | 264.22% | - | Upgrade
|
| Capital Expenditures | - | -5.07 | -6.67 | -14.59 | -12.76 | -27.29 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 0.18 | 0.99 | 0.76 | - | Upgrade
|
| Investment in Securities | - | 1.33 | -0.62 | -18.45 | -0.02 | -13.5 | Upgrade
|
| Other Investing Activities | - | 3.69 | 3.05 | 2 | 1.38 | 11.55 | Upgrade
|
| Investing Cash Flow | - | -0.05 | -4.06 | -30.05 | -10.64 | -29.23 | Upgrade
|
| Short-Term Debt Issued | - | 14.6 | - | 111.4 | - | - | Upgrade
|
| Total Debt Issued | - | 14.6 | - | 111.4 | - | - | Upgrade
|
| Short-Term Debt Repaid | - | - | -102.05 | - | -12.74 | -3.03 | Upgrade
|
| Long-Term Debt Repaid | - | - | - | - | - | -3.12 | Upgrade
|
| Total Debt Repaid | - | - | -102.05 | - | -12.74 | -6.15 | Upgrade
|
| Net Debt Issued (Repaid) | - | 14.6 | -102.05 | 111.4 | -12.74 | -6.15 | Upgrade
|
| Common Dividends Paid | - | -3.09 | -3.09 | -3.09 | - | - | Upgrade
|
| Other Financing Activities | - | -6.74 | -6.87 | -12.32 | -6.75 | -12.75 | Upgrade
|
| Financing Cash Flow | - | 4.77 | -112.01 | 95.99 | -19.49 | -18.9 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | - | - | -0 | Upgrade
|
| Net Cash Flow | - | -96.19 | -21.95 | -28.43 | 144.62 | -0.16 | Upgrade
|
| Free Cash Flow | - | -105.99 | 87.45 | -108.96 | 161.98 | 20.69 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | 682.87% | - | Upgrade
|
| Free Cash Flow Margin | - | -3.71% | 3.10% | -3.51% | 7.30% | 1.16% | Upgrade
|
| Free Cash Flow Per Share | - | -34.30 | 28.30 | -35.27 | 52.42 | 6.70 | Upgrade
|
| Cash Interest Paid | - | 6.74 | 6.87 | 12.32 | 6.75 | 12.75 | Upgrade
|
| Cash Income Tax Paid | - | 14.52 | 29.66 | 95 | 15.34 | 22.54 | Upgrade
|
| Levered Free Cash Flow | - | -124.04 | 85.05 | -126.9 | 134.99 | 2.56 | Upgrade
|
| Unlevered Free Cash Flow | - | -121 | 88.51 | -121.09 | 137.27 | 8.42 | Upgrade
|
| Change in Working Capital | - | -191.72 | 98.31 | -241.18 | -57.79 | -19.92 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.